Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin

BACKGROUND: Respiratory syncytial virus (RSV) is a major health care burden with a particularly high worldwide morbidity and mortality rate among infants. Data suggest that severe RSV-associated illness is in part caused by immunopathology associated with a robust type 2 response. OBJECTIVE: We soug...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Allergy Clin Immunol
Päätekijät: Stier, Matthew T., Bloodworth, Melissa H., Toki, Shinji, Newcomb, Dawn C., Goleniewska, Kasia, Boyd, Kelli L., Quitalig, Marc, Hotard, Anne L., Moore, Martin L., Hartert, Tina V., Zhou, Baohua, McKenzie, Andrew N., Peebles, R. Stokes
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Mosby 2016
Aiheet:
Immune Deficiencies, Infection, and Systemic Immune Disorders
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014571/
https://ncbi.nlm.nih.gov/pubmed/27156176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2016.01.050
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia